Presentations include first reporting of data for the RESET™ Clinical Trial evaluating SPRINT PNS versus Standard Interventional Management for low...
REHOVOT, Israel and WASHINGTON, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Biolojic Design, a biotechnology company that uses computational biology and...
– In two studies the acellular tissue engineered vessel (ATEV) provided benefits in terms of patency, limb salvage, and infection...
The Company's class A ordinary shares will begin trading on a split-adjusted basis on November 25, 2024FOSTER CITY, Calif., Nov....
MORRISVILLE, N.C., Nov. 21, 2024 (GLOBE NEWSWIRE) -- Science 37, a leader in enhancing patient access to clinical trials, was...
Made progress deploying all components of the Nanox solution including Nanox.ARC and Nanox.AI Expanded US sales and support staff a...
New seven-part series explores disparities in care, funding and innovation impacting half the world's population LONDON, Nov. 21, 2024 /PRNewswire/...
The $16M USD round was led by Celesta Capital, with participation from Tenacity Ventures, Cedars Sinai; OneCell to continue transforming...
TEL AVIV, Israel, Nov. 20, 2024 /PRNewswire/ -- Converge Bio, a generative AI platform for accelerated drug discovery and development, today...
"Senolytic Immunotherapy" is the basis of Immorta Bio's first-in-class oncology platform MIAMI BEACH, Fla., Nov. 20, 2024 /PRNewswire/ -- A...
Grant funding will support the new Syn-Q Clinical Study to further investigate the quantification of P-SYN in skin biopsies using CND's...
PHILADELPHIA, Nov. 20, 2024 /PRNewswire/ -- PolicyMap, an online data and mapping company, announced today the integration of Surgo Health's' Granular...
Program to provide investigational drug to ALS patients who would otherwise be ineligible for clinical trials SANTA CLARA, Calif., Nov....
NAPLES, FL / ACCESSWIRE / November 20, 2024 / Stemtech Corporation (OTCQB:STEK) and Seacret Direct, LLC (doing business as VIÁGO)...
Potential to redefine frontline AML treatment being evaluated in clinic: Mipletamig, CD3 x CD123 bispecific, in combination with standard of...
Potential to redefine frontline AML treatment being evaluated in clinic: Mipletamig, CD3 x CD123 bispecific, in combination with standard of...
Backed by a Strong Balance Sheet, MIRA Accelerates Toward Becoming a Clinical-Stage Company and Advancing Breakthroughs in Pain and Depression...
The Northwell Health Cancer Institute is the Most Recent Clinical Site to Join the TIGeR-PaC Study, and RenovoRx Aims to...
Combined organization will unlock patterns in complex participant populations, driving physical and mental health improvementWELLESLEY HILLS, Mass., Nov. 20, 2024...
HAMPTON, N.J., Nov. 20, 2024 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) today announced that the first patient has been...